Presentations

  1. “Extracellular Matrix and Endocytosis in Health and Disease: My Journey from Japan to the UK and Back” 済州大学校病院医生命研究院2026年地域医療研究能力強化事業　第2回セミナー、済州大学病院、韓国、2026年3月17日　https://www.tuat.ac.jp/NEWS/visit/20260417_01.html
  2. “Protein, Mouse & Global Networks” 第一回農獣スパークキャラバン、農工大府中キャンパス、邂逅館、日本　2026年3月10日　(口演).
  3. “Endocytic receptor LRP1 in cartilage homeostasis and destruction.”, 38th Annual Meeting of the Japanese Society of Cartilage Metabolism, Hiroshima, Japan, February 2026. (Oral presentation, first/corresponding author).
  4. “From Metalloproteinases to Endocytic Receptor LRP1: A Journey Through My Time in the UK.”, Tsukuba Advanced Research Alliance (TARA) Life Science Center Open seminar, Tsukuba, Japan, October 2025. (Invited speaker).
  5. “関節軟骨から全身の恒常性まで ~エンドサイトーシス受容体LRP1研究の展開~.”, the Central Institute for Experimental Medicine and Life Science (公益財団法人実中研), Kawasaki, Japan, September 2025. (Oral presentation).
  6. “Novel insights into the multifaceted and tissue-specific roles of the endocytic receptor LRP1.”, British Society for Matrix Biology (BSMB) Autumn Meeting, Surrey, UK, September 2025. (Oral and poster presentation, first/corresponding author).
  7. “Fibroblast LRP1 drives pulmonary fibrosis by mediating plasma membrane collagen fibril assembly.”, Japanese Society for Matrix Biology and Medicine Annual Meeting, Osaka, Japan, June 2025. (Oral presentation, corresponding/senior author). 
  8. “Fibroblast LRP1 drives pulmonary fibrosis by mediating plasma membrane collagen fibril assembly.”, British Society for Matrix Biology (BSMB) Spring Meeting, Nottingham, UK, April 2025. (Poster presentation, corresponding/senior author). 
  9. “The extracellular molecule clearance system in tissue homeostasis and destruction.”, SANTO Project: International Symposium on Osteoarthritis and Cartilage, Kanazawa University Hospital, Kanazawa, Japan, March 2025. (A co-organiser and speaker).
  10. “The extracellular molecule clearance system in tissue homeostasis and destruction.”, Advances in Biosciences Seminar at University of Manchester, Manchester, UK, November 2024. (Invited speaker).
  11. “Endocytic receptor LRP1 in tissue homeostasis, remodelling and destruction.”, CNR-Royal Society Network Meeting, Glasgow, UK, July 2024. (Invited speaker). 
  12. “Tissue- and context-dependent roles of the low-density lipoprotein receptor-related protein 1 in mouse models of osteoarthritis.”, Vienna, Austria, April 2024. (Poster presentation, first and corresponding author). 
  13. “Skeletal progenitor LRP1 deficiency causes severe and persistent skeletal defects with WNT dysregulation.”, British Society for Matrix Biology (BSMB) Spring Meeting, Bristol, UK, April 2024. (Oral presentation, senior author).
  14. “Tissue-Specific Proteomic Profiling in Bovine Dental Tissues.”, The International Association for Dental, Oral, and Craniofacial Research conference, New Orleans, LA, USA, March 2024. (Anders: Poster presentation, senior author)
  15. “Skeletal progenitor LRP1-mediated endocytosis is critical for synovial joint formation and bone growth”. 12th International Proteoglycan Conference/89th Harden Conference, Surrey, UK, SEP 2023. (Oral presentation, senior author).
  16. “Longitudinal microCT monitoring of mouse bones ”. 6th Annual Symposium of the Centre for Pre-clinical Imaging, Liverpool, UK, September, 2023. (Invited speaker, senior author).
  17. “Extraction of Bioactive Molecules for Vital Pulp Therapy Using Different EDTA Irrigation Protocols”. The European Society of Endodontology Biennial Congress, Helsinki, Finland, September, 2023. (Poster presentation, co-author).
  18. “Cell-surface receptor LRP1 in skeletal progenitor cells is critical for the formation of multiple skeletal elements.” British Society for Matrix Biology (BSMB) Spring Meeting, Sheffield, UK, April 2023. (Poster presentation). 
  19.  “Unravelling the Molecular Mechanisms of Dental Ageing and Disease: A Proteomic Study of Equine Teeth.” British Society for Matrix Biology (BSMB) Spring Meeting, Sheffield, UK, April 2023. (Senior author. Poster presentation). 
  20. “Cell-surface endocytic receptor LRP1 in skeletal progenitor cells is essential for shaping bone and cartilage.” The 50th European Calcified Tissue Society Congress, Liverpool, UK, April 2022. (Oral presentation). 
  21. “The cell-surface receptor LRP1 is a rapid responder and transducer of mechanical force”. Gordon Research Conference on Cartilage and Joint Pathology, II Ciocco, Italy, March, 2023. (Senior author. Best poster presentation prize awarded to Noor Al Al Maslamani).
  22. “LRP1 in skeletal precursors guides limb development through direct regulation of WNT signalling”. Gordon Research Conference on Cartilage and Joint Pathology, II Ciocco, Italy, March, 2023. (Poster presentation. Senior author.).
  23. “The cell-surface multifunctional receptor LRP1 in extracellular matrix turnover, morphogen signalling and mechano-adaptation”. BIO Open Lecture series, University of East Anglia, Norwich, UK, March 2023 (Invited speaker).
  24. “The emerging roles of LRP1 in skeletal development, lung fibrosis and mechano-adaptation”. CNR-Royal Society Network Meeting, University of East Anglia, Norwich, UK, March 2023 (Invited speaker).
  25. “A top-down approach to uncover the hidden ligandome of low-density lipoprotein receptor-related protein 1 in cartilage” The MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) Autumn Meeting, October 2022. (Oral presentation).
  26. “LRP1 is required for the excessive collagen deposition in bleomycin-induced lung fibrosis model.” Matrix Biology Europe 2022, Florence, Italy, September 2022.  (Senior author. Poster presentation, Travel Bursary Award). 
  27. “Optimisation of a proteomic workflow for the extraction of extracellular matrix proteins within dental tissues.” British Society for Matrix Biology (BSMB) Autumn Meeting, Liverpool, UK, September 2022. (Senior author. Poster presentation). 
  28. “The cell-surface receptor LRP1 is a rapid responder and transducer of mechanical force.” British Society for Matrix Biology (BSMB) Autumn Meeting, Liverpool, UK, September 2022. (Senior author. Poster presentation). 
  29. “Targeted inhibition of aggrecanase inhibits the progression of age-dependent cartilage degradation in a temporomandibular joint in the STR/Ort mice.” British Society for Matrix Biology (BSMB) Autumn Meeting, Liverpool, UK, September 2022. (Second author. Poster presentation). 
  30. “LaNt α31 induces an epithelial to mesenchymal-like transition in pancreatic adenocarcinoma cells and changes laminin α3 expression.” British Society for Matrix Biology (BSMB) Autumn Meeting, Liverpool, UK, September 2022. (Second senior author. Poster presentation). 
  31. “Interaction of Wnts and low-density lipoprotein receptor-related protein 1 in cartilage development.” British Society for Matrix Biology (BSMB) Autumn Meeting, Liverpool, UK, September 2022. (Senior author. Poster presentation). 
  32. “Transcriptional elements driving MMP13 in development.” British Society for Matrix Biology (BSMB) Autumn Meeting, Liverpool, UK, September 2022. (Second senior author. Oral and poster presentation). 
  33. “Increased LaNtα31 activates Akt signalling in breast cancer and changes the mode of tumour invasion into laminin matrixes.” British Society for Matrix Biology (BSMB) Autumn Meeting, Liverpool, UK, September 2022. (Second senior author. Poster presentation).
  34. “The low-density lipoprotein receptor-related protein 1 is essential for skeletal development.” Bone Research Society Annual meeting 2022, Manchester, UK, July 2022. (First author. Oral presentation).
  35. “A novel function of LRP1 as a mechano-receptor in joints.” Cutting Edge OA 2022, Oxford, UK, July 2022. (Senior author. Poster presentation (Noor). Travel bursary (Cutting Edge OA) and poster presentation prize awarded to Noor). 
  36. “Identification of novel and critical interaction of Wnts and low-density lipoprotein receptor-related protein 1 in cartilage.” Cutting Edge OA 2022, Oxford, UK, July 2022. (Senior author. Poster presentation (Abdulrahman). Travel bursary (CIMA) awarded to Abdulrahman Gremida). 
  37. “Targeted inhibition of aggrecanases inhibits the progression of age-dependent cartilage degradation in a temporomandibular joint in the STR/Ort mice.” Cutting Edge OA 2022, Oxford, UK, July 2022. (Second author. Oral presentation (Yutaka)).
  38. “Cell-surface receptor LRP1 in skeletal tissue homeostasis.” Cutting Edge OA 2022, Oxford, UK, July 2022. (Second senior author. Poster presentation (Mohammad). Poster pitch presentation prize awarded to Mohammad). 
  39. “Transcriptional elements in the MMP13 gene: Can we target it in osteoarthritis.” Cutting Edge OA 2022, Oxford, UK, July 2022. (Second senior author. Poster presentation (Sara)).
  40. “A top-down approach to uncover the hidden binding partners of low-density lipoprotein receptor-related protein 1 in cartilage.” Versus Arthritis Fellow’s meeting, Birmingham, UK, May 2022. (First author, oral presentation). 
  41. “Fibroblast-specific deletion of cell-surface endocytic receptor LRP1 prevents the development of pulmonary fibrosis in mouse in vivo.” British Society for Matrix Biology (BSMB) Spring Meeting, University of Oxford, UK, April 2021. (Senior author, poster presentation). 
  42. “Regulation of extracellular matrix turnover and remodelling by the cell-surface receptor LRP1-meditated endocytosis.” The MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) Spring Meeting, Virtual, February 2021. (Invited speaker).
  43. “Endocytosis of extracellular molecules in respiratory health and disease.” British Society for Matrix Biology (BSMB) Autumn Meeting, University of East Anglia, UK, September 2019. (Senior author, poster presentation). 
  44. “Inhibition of LRP1 shedding reverses cartilage matrix degradation in osteoarthritis.” OARSI World Congress on Osteoarthritis, Liverpool, UK, April 2018. (Oral presentation). 
  45. “Inhibition of shedding of low-density lipoprotein receptor-related protein 1 reverses cartilage matrix degradation in osteoarthritis.” British Society for Matrix Biology (BSMB) Spring Meeting, St Catherin’s College, University of Oxford, UK, April 2017. (Poster presentation). 
  46. “Development of an anti-ADAMTS-5 monoclonal antibody that specifically blocks interaction with LRP1.” London Matrix Group Autumn Symposium, William Harvey Research Institute, London, UK, October 2016. (Oral presentation).
  47. “LRP1-regulated extracellular trafficking of MMPs and ADAMTSs.” Gordon Research Conference on Matrix Metalloproteinases, Sunday River, Newry, Maine, USA, August, 2015. (Invited speaker).
  48. “MT1-MMP- and ADAM17-dependent LRP1 shedding increases extracellular activities of matrix-degrading metalloproteinases and induces cartilage degradation.” Cutting Edge Osteoarthritis, Pembroke College, Oxford, UK, June 2015. (Poster presentation).
  49. “The role of endocytic receptor LRP1 in cartilage.” Summer School, Arthritis Research UK. Centre for Osteoarthritis Pathogenesis, Kennedy Institute of Rheumatology, Oxford, UK, June 2014. (Oral presentation). 
  50. “Inflammatory cytokines and hypoxia regulates endocytosis of aggrecanases by stimulating LRP1 shedding.” British Society for Matrix Biology Spring Meeting, University of Bristol, 7-8 April, 2014. (Oral and poster presentations).
  51. “LRP1-mediated endocytic clearance of ADAMTS-4: Comparative studies with ADAMTS-5.” Gordon Research Conference on Matrix Metallproteinases, II Ciocco, Italy, May, 2013. (Poster presentation).
  52. “LRP-1-Mediated Endocytic Clearance Regulates ADAMTS-5 Activity in Articular Cartilage.” Gordon Research Conference on Matrix Metallproteinases, Bryant University, Rhode Island, USA, August, 2011. (Poster presentation, Outstanding Research Poster Award).
  53. “LRP-1-Mediated Endocytic Clearance Regulates ADAMTS-5 Activity in Articular Cartilage.”  Winter School on Proteinases and Their Inhibitors, Tiers, Italy, February, 2010. (Oral presentation, Best Scientific Presentation Award- 2nd Place).
  54. “Interaction between matrix metalloproteinase-7 (MMP-7) and cholesterol sulfate alters substrate preference of the protease: Implications for pericellular proteolysis and cancer metastasis.” Gordon Research Conference, Matrix Metallproteinases, Les Diablerets, Switzerland, August-September, 2009. (Poster presentation).
  55. “Matrilysin (matrix metalloproteinase-7) is a processing enzyme for human laminin332 (laminin-5).” Pan Pacific Connective Tissue Societies Symposium, Cairns, Australia, October, 2007. (Poster presentation).
  56. “Binding of active matrilysin to cell surface cholesterol sulfate is essential for its membrane-associated proteolytic action and induction of homotypic cell adhesion.” IUBMB International Congress of Biochemistry and Molecular Biology and FAOBMB Congress, Kyoto, Japan, June, 2006. (Poster presentation).
  57. “Human active matrilysin binds to cholesterol sulfate on cell surface to modulate cell surface proteins.” General Meeting of the International Proteolysis Society, Quebec, Canada, October, 2005. (Poster presentation).